Andreas O Stucki
Overview
Explore the profile of Andreas O Stucki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma M, Huber E, Arnesdotter E, Behrsing H, Bettmann A, Brandwein D, et al.
Arch Toxicol
. 2024 Oct;
99(1):57-66.
PMID: 39365315
Standard information reporting helps to ensure that assay conditions and data are consistently reported and to facilitate inter-laboratory comparisons. Here, we present recommendations on minimum information for reporting on the...
2.
Stucki A, Sauer U, Allen D, Kleinstreuer N, Perron M, Yozzo K, et al.
Regul Toxicol Pharmacol
. 2024 May;
150:105648.
PMID: 38772524
Inhalation is a critical route through which substances can exert adverse effects in humans; therefore, it is important to characterize the potential effects that inhaled substances may have on the...
3.
Sharma M, Stucki A, Verstraelen S, Stedeford T, Jacobs A, Maes F, et al.
Toxicol Sci
. 2023 Jul;
195(2):213-230.
PMID: 37498623
Inhalation is a major route by which human exposure to substances can occur. Resources have therefore been dedicated to optimize human-relevant in vitro approaches that can accurately and efficiently predict...
4.
Sengupta A, Dorn A, Jamshidi M, Schwob M, Hassan W, De Maddalena L, et al.
Front Pharmacol
. 2023 Mar;
14:1114739.
PMID: 36959848
Prolonged exposure to environmental respirable toxicants can lead to the development and worsening of severe respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis. The limited number...
5.
Patel V, Amin K, Wahab A, Marimoutou M, Ukishima L, Alvarez J, et al.
Toxicol Sci
. 2023 Jan;
191(2):253-265.
PMID: 36617185
Human precision-cut lung slices (hPCLS), considered a highly relevant ex vivo model of the lung, offer native architecture and cells of the lung tissue including respiratory parenchyma, small airways, and...
6.
Lee K, Corley R, Jarabek A, Kleinstreuer N, Paini A, Stucki A, et al.
Toxics
. 2022 Dec;
10(12).
PMID: 36548593
New approach methodologies (NAMs) are emerging chemical safety assessment tools consisting of in vitro and in silico (computational) methodologies intended to reduce, refine, or replace (3R) various in vivo animal...
7.
Stucki A, Clippinger A, Henry T, Hirn C, Stedeford T, Terry C
Front Toxicol
. 2022 Nov;
4:1048900.
PMID: 36438078
No abstract available.
8.
Miller-Holt J, Behrsing H, Clippinger A, Hirn C, Stedeford T, Stucki A
Front Toxicol
. 2022 Sep;
4:943358.
PMID: 36157974
Regulatory frameworks on tobacco and other nicotine-containing products (TNCP) continue to evolve as novel products emerge, including electronic nicotine delivery systems (e.g., electronic cigarettes or vaping products), heated tobacco products,...
9.
Stucki A, Barton-Maclaren T, Bhuller Y, Henriquez J, Henry T, Hirn C, et al.
Front Toxicol
. 2022 Sep;
4:964553.
PMID: 36119357
New approach methodologies (NAMs) are increasingly being used for regulatory decision making by agencies worldwide because of their potential to reliably and efficiently produce information that is fit for purpose...
10.
Chary A, Groff K, Stucki A, Contal S, Stoffels C, Cambier S, et al.
Toxicol In Vitro
. 2022 Jun;
83:105423.
PMID: 35753526
Scientists are using in vitro methods to answer important research questions and implementing strategies to maximize the reliability and human relevance of these methods. One strategy is to replace the...